Frailty phenotype and chronic kidney disease: a review of the literature

International Urology and Nephrology

Volumn 47, Issue 11, 2015, Pages 1801-1807

  Musso, Carlos G ^a   Jauregui, Jose R ^a   Macías Núñez, Juan F ^b  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Chronic kidney disease; Dialysis; Elderly; Frailty phenotype

Indexed keywords

CREATININE;

AEROBIC EXERCISE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; EXERCISE INTENSITY; FAT MASS; FRAIL ELDERLY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FUNCTION; MUSCLE MASS; PHENOTYPE; PHYSICAL PERFORMANCE; RESISTANCE TRAINING; REVIEW; SARCOPENIA; VITAMIN SUPPLEMENTATION; AGED; COMPLICATION; ENDURANCE; HAND STRENGTH; HEALTH STATUS; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; WALKING; WEIGHT REDUCTION;

AGED; FRAIL ELDERLY; HAND STRENGTH; HEALTH STATUS; HUMANS; MUSCLE WEAKNESS; PHENOTYPE; PHYSICAL ENDURANCE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SARCOPENIA; WALKING; WEIGHT LOSS;

EID: 84946477114     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-015-1112-z     Document Type: Review

References (49)

1. Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, Seliger S, Ruzinski J, Himmelfarb J, Kestenbaum B (2012) A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 60(6):912–921
2. Johansen KL, Delgado C, Bao Y, Kurella Tamura M (2013) Frailty and dialysis initiation. Semin Dial 26(6):690–696
3. Studenski S (2011) Gait speed and survival in older adults. JAMA 305(1):50–58
4. Romero-Cabrera AJ (2011) Frailty and chronic diseases in the elderly. Int Mex 27(5):455–462
5. Johansen KL, Chertow GM, Jin C, Kutner NG (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18(11):2960–2967
6. Bonanni A, Mannucci I, Verzola D, Sofia A, Saffioti S, Gianetta E, Garibotto G (2011) Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health 8(5):1631–1635
7. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156
8. Walker SR, Gill K, Macdonald K, Komenda P, Rigatto C, Sood MM, Bohm CJ, Storsley LJ, Tangri N (2013) Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol 22(14):228. doi:10.1186/1471-2369-14-228
9. Ayaz T, Sahin SB, Sahin OZ, Bilir O, Rakıcı H (2014) Factors affecting mortality in elderly patients hospitalized for nonmalignant reasons. J Aging Res 2014:584315. doi:10.1155/2014/584315
10. Forciea M, Lavizzo-Mourey R, Schwab E (2000) Geriatric secrets. Hanley & Belfus, Philadelphia
11. McAdams-DeMarco MA, Law A, Salter ML, Boyarsky B, Gimenez L, Jaar BG, Walston JD, Segev DL (2013) Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc 61(6):896–901
12. Montero-Odasso M, Schapira M, Soriano ER, Varela M, Kaplan R, Camera LA, Mayorga LM (2005) Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. J Gerontol A Biol Sci Med Sci. 60(10):1304–1309
13. Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, Cesari M, Chumlea WC, Doehner W, Evans J, Fried LP, Guralnik JM, Katz PR, Malmstrom TK, McCarter RJ, Gutierrez Robledo LM, Rockwood K, von Haehling S, Vandewoude MF, Walston J (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14(6):392–397
14. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423
15. Buford TW, Anton SD, Judge AR, Marzetti E, Wohlgemuth SE, Carter CS, Leeuwenburgh C, Pahor M, Manini TM (2010) Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev 9(4):369–383
16. Shastri S, Katz R, Rifkin DE, Fried LF, Odden MC, Peralta CA, Chonchol M, Siscovick D, Shlipak MG, Newman AB, Sarnak MJ (2012) Kidney function and mortality in octogenarians: cardiovascular Health Study All Stars. J Am Geriatr Soc 60(7):1201–1207
17. Feng L, Yap KB, Yeoh LY, Ng TP (2012) Kidney function and cognitive and functional decline in elderly adults: findings from the Singapore longitudinal aging study. J Am Geriatr Soc 60(7):1208–1214
18. Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ (2008) Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168(20):2212–2218
19. Tessari P, Deferrari G, Robaudo C, Vettore M, Pastorin N, De Biasi L, Garibotto G (1999) Phenylalanine hydroxylation across the kidney in humans. Kidney Int 56:2168–2172
20. Garibotto G, Valli A, Anderstam B, Eriksson M, Suliman M, Balbi M, Rollando D, Vigo E, Lindholm B (2009) The kidney is a major site of S-adenosylhomocysteine disposal in humans. Kidney Int 76:293–296
21. Baylis C (2006) Arginine, arginine analogous and nitric oxid production in chronic kidney disease. Nat Clin Pract Nephrol 2:209–220
22. Sun DF, Zheng Z, Tummala P, Oh J, Schaefer F, Rabkin R (2004) Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle. J Am Soc Nephrol 15:2630–2646
23. Chen Y, Biada J, Sood S, Rabkin R (2010) Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation. Kidney Int 78:89–95
24. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Baltimore longitudinal study of aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86:724–731
25. Morley JE, Melmed S (1979) Gonadal dysfunction in systemic disorders. Metabolism 28:1051–1073
26. Bailey JL, Zheng B, Hu Z, Price SR, Mitch WE (2006) Chronic kidney disease causes defects in signalling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol 17:1388–1394
27. Pupim LB, Flakoll PJ, Majchrzak KM (2005) Aftab Guy DL, Stenvinkel P, Ikizler TA. Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. Kidney Int 68:1857–1865
28. Vanholder R, Ringoir S (1993) Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 3:1541–1554
29. Nguyen-Khoa T, Massay ZA, De Bandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drüeke TB, Lacour B, Thévenin M (2001) Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transpl 16:335–340
30. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Giovannini L, Norpoth M, Metelli MR, Cristofani R, Bertelli AA, Sbragia G, Tetta C, Palla R, Colombo R (2002) C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron 91:594–600
31. Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL (2012) Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 172(14):1071–1077
32. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J (2004) Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 65:1031–1040
33. Macías Núñez JF, Ghais Z, Bustamante J, Lopez-Novoa JM, Arrieta J, Barril G, Del Pino MD, Escaja C, Martín IM, Fernández Andrade C, García F, Núñez J, Onaindía JM, González J, Pérez-Prieto M, Fernández M, Lopez J, Santiago JM, Vicens M, Sousa F (2010) Evaluation of oxidant-antioxidant balance in patients on maintenance haemodialysis: a comparative study ofdialyzers membranes. Nephron Clin Pract 114(1):c67–c73
34. Huang CX, Tighiouart H, Beddhu S, Cheung AK, Dwyer JT, Eknoyan G, Beck GJ, Levey AS, Sarnak MJ (2010) Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int 77:624–629
35. Kutner NG, Zhang R, Huang Y, Wasse H (2014) Gait speed and hospitalization among ambulatory hemodialysis patients: USRDS special study data. World J Nephrol 3(3):101–106
36. Arnold RM, Zeidel ML (2009) Dialysis in frail elders—a role for palliative care. N Engl J Med 361(16):1597–1598
37. Burns A, Davenport A (2010) Functional status of elderly adults receiving dialysis. N Engl J Med 362(5):468
38. Jassal SV, Chiu E, Hladunewich M (2009) Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 361(16):1612–1613
39. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361(16):1539–1547
40. Roderick PJ (2011) Chronic kidney disease in older people: a cause for concern? Nephrol Dial Transpl 26(10):3083–3086
41. Musso CG, Trigka K, Dousdampanis P, Jauregui J (2015) Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature. Int Urol Nephrol 47(4):647–654
42. Johansen KL, Chertow GM, Jin C, Kutner NG (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18(11):2960–2967
43. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495
44. Jauregui JR, Kecskes C, Patiño O, Musso CG, Galich A, Rodota L (2012) Sarcopenia. A relevant entity in the very elderly. Rev Hop Ital B Aires 32(4):162–168
45. Painter P, Kuskowski M (2013) A closer look at frailty in ESRD: getting the measure right. Hemodial Int 17(1):41–49
46. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381(9868):752–762. doi: 10.1016/S0140-6736(12)62167-9. Review. Erratum in: Lancet. 2013 Oct 19;382(9901):1328
47. Boirie Y, Gachon P, Cordat N, Ritz P, Beaufrère B (2001) Differential insulin sensitivities of glucose, amino acid, and albumin metabolism in elderly men and women. J Clin Endocrinol Metab 86:638–644
48. Katz S, Akpom CA (1976) A measure of primary sociobiological functions. Int J Health Serv 6:493–508
49. Pianta TF, Kutner NG (1999) Improving physical functioning in the elderly dialysis patient: relevance of physical therapy. ANNA J 26(1):11–14